The cancer diagnostics and treatment company priced shares above their earlier target range and might signal a renewed appetite for biotech listings. On Wednesday morning, the cancer diagnostics ...

Initial public offerings (IPOs) just keep on coming in 2025 and they continue to remain in heavy demand. Companies have ...

Cancer-testing company raises $494 million in initial public offering.

Caris Life Sciences CEO and chairman David Dean Halbert, celebrates the company's initial public offering and listing on the Nasdaq exchange by ringing the opening bell on Wednesday, June 18, 2025.

Caris Life Sciences bumped up the pricing of its IPO to raise more than $494.1 million in its Nasdaq debut—well over the range it first proposed last week, in the vicinity of $400 million.. The ...

The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion. Caris Life Sciences, a cancer diagnostics company based in Irving, Texas, uses gene ...

Caris Life Sciences shares rose on their first day of trading in their debut on Nasdaq. The biotechnology company started trading at $27 each on Wednesday afternoon, a day after the company's IPO ...

Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.3 billion in its U.S. initial public offering, as the market for new listings rebounds.

IRVING, Texas, June 17, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a ... option to purchase up to an additional 3,529,411 shares of common stock at the initial public offering ...

Caris Life Sciences (CAI) priced 23.53M shares at $21.00. The deal priced above the $19.00-$20.00 range. BofA, JPMorgan and Goldman Sachs acted as joint book running managers for the offering.

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its ...

Caris Life Sciences’s IPO will offer 23,529,412 shares. Founder and CEO Halbert is also set to retain 41.7% of ownership following the IPO. This post originally appeared at fastcompany.com ...